Trademark: 77273787
Word
IPILIMUMAB
Status
Dead
Status Code
710
Status Date
Friday, April 8, 2016
Serial Number
77273787
Registration Number
3677086
Registration Date
Tuesday, September 1, 2009
Mark Type
3000
Filing Date
Friday, September 7, 2007
Published for Opposition
Tuesday, March 11, 2008
Cancellation Date
Friday, April 8, 2016

Trademark Owner History
Bristol-Myers Squibb Company - Original Registrant

Classifications
42 medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use
Color is not claimed as a feature of the mark.
"IPILIMUMAB"
The mark consists of a stylized double helix and cells and the word "IPILIMUMAB" in stylized lettering.

Trademark Events
Apr 8, 2016
Cancelled Sec. 8 (6-Yr)
Apr 19, 2011
Attorney Revoked And/Or Appointed
Apr 19, 2011
Teas Revoke/Appoint Attorney Received
Sep 1, 2009
Registered-Principal Register
Jul 24, 2009
Law Office Registration Review Completed
Jul 23, 2009
Allowed Principal Register - Sou Accepted
Jul 13, 2009
Statement Of Use Processing Complete
Jun 17, 2009
Use Amendment Filed
Jul 10, 2009
Case Assigned To Intent To Use Paralegal
Jun 17, 2009
Teas Statement Of Use Received
May 14, 2009
Extension 2 Granted
May 14, 2009
Extension 2 Filed
May 14, 2009
Teas Extension Received
Nov 17, 2008
Extension 1 Granted
Nov 17, 2008
Extension 1 Filed
Nov 17, 2008
Teas Extension Received
Jun 3, 2008
Noa Mailed - Sou Required From Applicant
Mar 11, 2008
Published For Opposition
Feb 20, 2008
Notice Of Publication
Feb 5, 2008
Law Office Publication Review Completed
Jan 26, 2008
Assigned To Lie
Dec 13, 2007
Approved For Pub - Principal Register
Dec 13, 2007
Assigned To Examiner
Sep 12, 2007
Notice Of Design Search Code Mailed
Sep 11, 2007
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24